within Pharmacolibrary.Drugs.V_Various.V04C_OtherDiagnosticAgents.V04CE01_Galactose;

model Galactose
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 7e-05,
    adminDuration = 600,
    adminMass = 400 / 1000000,
    adminCount = 1,
    Vd = 0.00035,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Galactose</td></tr><tr><td>ATC code:</td><td>V04CE01</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>400</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.35</td><td>L</td></tr>
    <tr><td>clearance:</td><td>60</td><td>ml/min/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Galactose is a monosaccharide sugar, part of the lactose disaccharide found in milk. It is used rarely as a diagnostic agent for liver function and galactose metabolism disorders, but is not an approved medication for therapeutic use in most countries today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult healthy individuals. No definitive PK profile reported in literature for therapeutic use; estimates derived based on monosaccharide similarities and diagnostic use.</p><h4>References</h4><ol><li><p>Mion, F, et al., &amp; Minaire, Y (1999). [13C]-Galactose breath test: correlation with liver fibrosis in chronic hepatitis C. <i>European journal of clinical investigation</i> 29(7) 624–629. DOI:<a href=\"https://doi.org/10.1046/j.1365-2362.1999.00512.x\">10.1046/j.1365-2362.1999.00512.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10411669/\">https://pubmed.ncbi.nlm.nih.gov/10411669</a></p></li><li><p>Joffe, P, et al., &amp; Sidhu, J (1998). Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects. <i>European journal of clinical pharmacology</i> 54(3) 237–242. DOI:<a href=\"https://doi.org/10.1007/s002280050452\">10.1007/s002280050452</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9681666/\">https://pubmed.ncbi.nlm.nih.gov/9681666</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.V.V04CE01 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Galactose;
